Abstract |
We evaluated the effectiveness of targeted cytotoxic analog of somatostatin (SST) AN-238, consisting of 2-pyrrolinodoxorubicin (AN-201) linked covalently to SST octapeptide carrier RC-121 in DU-145 human androgen-independent prostate cancers xenografted into nude mice. We also investigated the expression of mRNAs for SST receptor subtypes 2A and 5 (sst2A and sst5) in DU-145 tumors. After 8 weeks of treatment, AN-238 practically arrested the proliferation of DU-145 cancers. The tumor volume in nude mice that received 4 injections of AN-238 at the dose of 150 nmol/kg was 63.4+/-6.7 mm3, nearly 4 times smaller than that in controls which measured 249.1+/-36.3 mm3 (p<0.001). Treatment with AN-238 lowered tumor weight by 68% (p<0.01) compared with the control group and extended the tumor volume doubling time to 184.1+/-69.4 days, versus 32.1+/-6.6 days in controls (p<0.05). No toxicity-related deaths occurred during treatment with AN-238. Cytotoxic radical AN-201 administered alone or in an unconjugated mixture with carrier RC-121 inhibited the growth of DU-145 tumors only after the third and fourth injection and was toxic. The expression of mRNA for sst2A and sst5 was detected in all specimens of control DU-145 tumors and in tumors treated with AN-238. The present study demonstrates the high efficacy of SST-receptor-targeted chemotherapy in a model of human androgen-independent prostatic carcinoma.
|
Authors | Artur Plonowski, Andrew V Schally, Attila Nagy, Baodong Sun, Gabor Halmos |
Journal | International journal of oncology
(Int J Oncol)
Vol. 20
Issue 2
Pg. 397-402
(Feb 2002)
ISSN: 1019-6439 [Print] Greece |
PMID | 11788908
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- AN 238
- Antibiotics, Antineoplastic
- Cytotoxins
- Pyrroles
- RNA, Messenger
- RNA, Neoplasm
- AN 204
- Doxorubicin
- RC 121
- Octreotide
|
Topics |
- Animals
- Antibiotics, Antineoplastic
(pharmacology, therapeutic use)
- Cell Division
(drug effects)
- Cytotoxins
(pharmacology, therapeutic use)
- Doxorubicin
(analogs & derivatives, pharmacology, therapeutic use)
- Gene Expression Regulation, Neoplastic
- Humans
- Male
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Neoplasms, Experimental
(drug therapy, pathology)
- Octreotide
(analogs & derivatives, pharmacology)
- Prostatic Neoplasms
(drug therapy, pathology)
- Pyrroles
(pharmacology, therapeutic use)
- RNA, Messenger
(genetics, metabolism)
- RNA, Neoplasm
(genetics, metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
- Treatment Outcome
- Tumor Cells, Cultured
|